Comments

Akari Therapeutics

AKTXNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$3.22
-0.02-0.62%
At Close: -
$3.15
-0.07-2.17%
After Hours: Sep 13, 4:52 PM EDT
15 minutes delayed
Akari Therapeutics (AKTX) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Akari Therapeutics (NASDAQ:AKTX) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Akari Therapeutics (AKTX)?

A

There have been no specific sales or earnings guidance reported for Akari Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch